Brief: Biophytis: Favorable Recommendation From DMC Based On Safety Analysis Of Sarconeos

Biophytis SA

16/08/2021 07:06

Aug 16 (Reuters) - Biophytis SA  ALBPS.PA :
    * BIOPHYTIS RECEIVES FAVORABLE RECOMMENDATION FROM DATA
MONITORING
COMMITTEE (DMC) BASED ON SAFETY ANALYSIS OF SARCONEOS (BIO101)
TO CONTINUE PATIENT RECRUITMENT IN THE COVA STUDY IN COVID-19
    * BIOPHYTIS SA - INDEPENDENT DMC (DATA MONITORING COMMITTEE)
OF
COVA STUDY RECOMMENDS TO CONTINUE PATIENTS RECRUITMENT INTO PART
2 OF PHASE 2-3 STUDY FOLLOWING RANDOMIZATION OF FIRST 155
PATIENTS
    * BIOPHYTIS SA - TOP LINE RESULTS OF FULL STUDY ON 310
PATIENTS
ARE EXPECTED IN Q4 2021, DEPENDING ON COVID-19 PANDEMIC
    * BIOPHYTIS SA - EFFICACY DATA FROM SECOND INTERIM ANALYSIS
IS
EXPECTED TO BE REVIEWED BY DMC IN Q3 2021

Source text for Eikon:  ID:nGNX5LbJ25 
Further company coverage:  ALBPS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))